EryDex System
IEDAT-03-2018
Phase 3 other terminated
Quick answer
EryDex System for Ataxia Telangiectasia is a Phase 3 program (other) at Quince Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Quince Therapeutics
- Indication
- Ataxia Telangiectasia
- Phase
- Phase 3
- Modality
- other
- Status
- terminated